CT-P43 + Stelara
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Psoriasis
Conditions
Psoriasis
Trial Timeline
Jan 11, 2021 → May 12, 2022
NCT ID
NCT04673786About CT-P43 + Stelara
CT-P43 + Stelara is a phase 3 stage product being developed by Celltrion for Psoriasis. The current trial status is completed. This product is registered under clinical trial identifier NCT04673786. Target conditions include Psoriasis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04673786 | Phase 3 | Completed |
Competing Products
20 competing products in Psoriasis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ixekizumab + Placebo | Eli Lilly | Phase 2 | 52 |
| VTX958 Dose A + VTX958 Dose B + VTX958 Dose C + VTX958 Dose D + Placebo | Ventyx Biosciences | Phase 2 | 47 |
| LY2525623 Intravenous + LY2525623 Subcutaneous + Placebo Intravenous + Placebo Subcutaneous | Eli Lilly | Phase 2 | 52 |
| Ixekizumab | Eli Lilly | Phase 3 | 77 |
| 80 mg Ixekizumab Dosing Regimens 1, 2, and 3 + Placebo | Eli Lilly | Phase 3 | 77 |
| Placebo + Baricitinib | Eli Lilly | Phase 2 | 52 |
| CT-P17 + EU-approved Humira | Celltrion | Phase 3 | 77 |
| CT-P55 + EU-approved Cosentyx | Celltrion | Phase 3 | 77 |
| AMG 139 | AstraZeneca | Phase 1 | 33 |
| alefacept + polyvalent pneumococcal vaccine | Astellas Pharma | Approved | 85 |
| alefacept | Astellas Pharma | Phase 2 | 52 |
| Tacrolimus Cream | Astellas Pharma | Phase 3 | 77 |
| alefacept | Astellas Pharma | Phase 3 | 77 |
| peficitinib + Placebo | Astellas Pharma | Phase 2 | 52 |
| Alefacept | Astellas Pharma | Phase 3 | 77 |
| Amevive exposure | Astellas Pharma | Pre-clinical | 23 |
| alefacept + placebo | Astellas Pharma | Phase 3 | 77 |
| alefacept | Astellas Pharma | Approved | 85 |
| ASKP1240 + Placebo | Astellas Pharma | Phase 2 | 52 |
| Tacrolimus Cream | Astellas Pharma | Phase 3 | 77 |
Other Products from Celltrion
Azathioprine + PlaceboApproved
85
Infliximab CT-P13 + Immunosuppressors (Thiopurines or Methotrexate)Approved
85
Infliximab + Infliximab + InfliximabApproved
85
Pioglitazone + Alogliptin + Alogliptin + Metformin + DapagliflozinApproved
85
Pioglitazone 15 MG [Actos] + Empagliflozin 10 MG [Jardiance] + Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]Approved
85